Evidence map›Paper›PMID 36907437›Full record

ArticleThe Journal of biological chemistry2023

Bifunctional DEGS2 has higher hydroxylase activity toward substrates with very-long-chain fatty acids in the production of phytosphingosine ceramides.

Ai Ota, Hiroya Morita, Tatsuro Naganuma, Masatoshi Miyamoto, Keisuke Jojima, Koki Nojiri, Junko Matsuda, Akio Kihara

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Ceramides and the Defective Barrier in Atopic Dermatitis.Skin pharmacology and physiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Skin Lipid Barrier: Structure, Function and Metabolism.Allergy, asthma & immunology research · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ai OtaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Hiroya MoritaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Tatsuro NaganumaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Masatoshi MiyamotoFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Keisuke JojimaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Koki NojiriFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Junko MatsudaDepartment of Pathophysiology and Metabolism, Kawasaki Medical School, Okayama, Japan.
Akio KiharaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan. Electronic address: kihara@pharm.hokudai.ac.jp.
Hokkaido University · JPKawasaki Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phytosphingosine (PHS) is a sphingolipid component present mainly in epithelial tissues, including the epidermis and those lining the digestive tract. DEGS2 is a bifunctional enzyme that produces ceramides (CERs) containing PHS (PHS-CERs) via hydroxylation and sphingosine-CERs via desaturation, using dihydrosphingosine-CERs as substrates. Until now, the role of DEGS2 in permeability barrier functioning, its contribution to PHS-CER production, and the mechanism that differentiates between these two activities have been unknown. Here, we analyzed the barrier functioning of the epidermis, esophagus, and anterior stomach of Degs2 KO mice and found that there were no differences between Degs2 KO and WT mice, indicating normal permeability barriers in the KO mice. In the epidermis, esophagus, and anterior stomach of Degs2 KO mice, PHS-CER levels were greatly reduced relative to WT mice, but PHS-CERs were still present. We obtained similar results for DEGS2 KO human keratinocytes. These results indicate that although DEGS2 plays a major role in PHS-CER production, another synthesis pathway exists as well. Next, we examined the fatty acid (FA) composition of PHS-CERs in various mouse tissues and found that PHS-CER species containing very-long-chain FAs (≥C21) were more abundant than those containing long-chain FAs (C11-C20). A cell-based assay system revealed that the desaturase and hydroxylase activities of DEGS2 toward substrates with different FA chain lengths differed and that its hydroxylase activity was higher toward substrates containing very-long-chain FAs. Collectively, our findings contribute to the elucidation of the molecular mechanism of PHS-CER production.

Indexed as

CeramidesFatty Acid DesaturasesFatty AcidsAnimalsCell Line, TumorEpidermisGene Knockout TechniquesHEK293 CellsHumansKeratinocytesMiceMice, Inbred C57BLMice, KnockoutMixed Function OxygenasesMultienzyme ComplexesOxidoreductasesCeramidesDEGS2 protein, humanDegs2 protein, mouseFatty Acid DesaturasesFatty AcidsMixed Function OxygenasesMultienzyme ComplexesOxidoreductasesphytosphingosineSphingosinebifunctional enzymeceramideenzyme mechanismepidermislipidpermeabilitysphingolipid

Identifiers

PMID36907437
PMCPMC10140171
OpenAlexW4323830916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.